Annual SG&A:
$7.25B-$40.98M(-0.56%)Summary
- As of today, TAK annual SG&A is $7.25 billion, with the most recent change of -$40.98 million (-0.56%) on March 31, 2025.
- During the last 3 years, TAK annual SG&A has fallen by -$640.97 million (-8.13%).
- TAK annual SG&A is now -18.33% below its all-time high of $8.87 billion, reached on March 31, 2020.
Performance
TAK SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$1.72B-$51.62M(-2.92%)Summary
- As of today, TAK quarterly SG&A is $1.72 billion, with the most recent change of -$51.62 million (-2.92%) on September 1, 2025.
- Over the past year, TAK quarterly SG&A has dropped by -$78.40 million (-4.36%).
- TAK quarterly SG&A is now -46.11% below its all-time high of $3.19 billion, reached on March 31, 2012.
Performance
TAK Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
$31.94B-$2.23B(-6.53%)Summary
- As of today, TAK TTM SG&A is $31.94 billion, with the most recent change of -$2.23 billion (-6.53%) on September 1, 2025.
- Over the past year, TAK TTM SG&A has increased by +$24.68 billion (+339.94%).
- TAK TTM SG&A is now -72.45% below its all-time high of $115.93 billion.
Performance
TAK TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
TAK Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -0.6% | -4.4% | +339.9% |
| 3Y3 Years | -8.1% | -4.4% | +324.0% |
| 5Y5 Years | -18.3% | -15.6% | +274.3% |
TAK Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -8.1% | at low | -11.4% | at low | -30.9% | at low |
| 5Y | 5-Year | -18.3% | at low | -22.2% | at low | -40.7% | at low |
| All-Time | All-Time | -18.3% | +662.9% | -46.1% | >+9999.0% | -72.5% | +86.2% |
TAK Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $1.72B(-2.9%) | $7.21B(-1.1%) |
| Jun 2025 | - | $1.77B(-8.8%) | $7.29B(+0.5%) |
| Mar 2025 | $7.25B(-0.6%) | $1.94B(+9.3%) | $7.25B(+0.3%) |
| Dec 2024 | - | $1.78B(-1.2%) | $7.23B(-0.5%) |
| Sep 2024 | - | $1.80B(+3.7%) | $7.26B(+0.7%) |
| Jun 2024 | - | $1.73B(-9.8%) | $7.21B(-1.0%) |
| Mar 2024 | $7.29B(-1.0%) | $1.92B(+6.2%) | $7.28B(-0.0%) |
| Dec 2023 | - | $1.81B(+3.4%) | $7.29B(-0.6%) |
| Sep 2023 | - | $1.75B(-3.0%) | $7.33B(-0.7%) |
| Jun 2023 | - | $1.80B(-6.3%) | $7.38B(+0.3%) |
| Mar 2023 | $7.36B(-6.7%) | $1.92B(+3.8%) | $7.36B(+0.0%) |
| Dec 2022 | - | $1.85B(+3.2%) | $7.36B(-2.4%) |
| Sep 2022 | - | $1.80B(+0.9%) | $7.53B(-1.7%) |
| Jun 2022 | - | $1.78B(-7.2%) | $7.66B(-2.9%) |
| Mar 2022 | $7.89B(-4.5%) | $1.92B(-5.5%) | $7.89B(-3.5%) |
| Dec 2021 | - | $2.03B(+5.5%) | $8.18B(-1.2%) |
| Sep 2021 | - | $1.93B(-4.2%) | $8.28B(-1.3%) |
| Jun 2021 | - | $2.01B(-9.0%) | $8.39B(+1.5%) |
| Mar 2021 | $8.26B(-6.9%) | $2.21B(+3.7%) | $8.26B(-1.4%) |
| Dec 2020 | - | $2.13B(+4.6%) | $8.37B(-1.9%) |
| Sep 2020 | - | $2.04B(+8.3%) | $8.53B(-0.5%) |
| Jun 2020 | - | $1.88B(-19.0%) | $8.58B(-3.3%) |
| Mar 2020 | $8.87B(+37.1%) | $2.32B(+1.3%) | $8.87B(-1.4%) |
| Dec 2019 | - | $2.29B(+10.2%) | $9.00B(+11.5%) |
| Sep 2019 | - | $2.08B(-4.4%) | $8.07B(+10.2%) |
| Jun 2019 | - | $2.18B(-11.2%) | $7.33B(+13.1%) |
| Mar 2019 | $6.47B(+14.2%) | $2.45B(+79.6%) | $6.48B(+15.4%) |
| Dec 2018 | - | $1.36B(+2.3%) | $5.61B(-0.8%) |
| Sep 2018 | - | $1.33B(+0.4%) | $5.66B(-0.5%) |
| Jun 2018 | - | $1.33B(-16.2%) | $5.69B(+0.3%) |
| Mar 2018 | $5.67B(-0.9%) | $1.59B(+12.6%) | $5.67B(+0.1%) |
| Dec 2017 | - | $1.41B(+3.3%) | $5.67B(+1.0%) |
| Sep 2017 | - | $1.36B(+4.0%) | $5.61B(-1.1%) |
| Jun 2017 | - | $1.31B(-17.1%) | $5.68B(-0.5%) |
| Mar 2017 | $5.72B(+5.5%) | $1.58B(+16.7%) | $5.71B(+1.1%) |
| Dec 2016 | - | $1.36B(-5.0%) | $5.65B(+0.4%) |
| Sep 2016 | - | $1.43B(+6.2%) | $5.63B(+3.4%) |
| Jun 2016 | - | $1.34B(-11.7%) | $5.44B(+0.2%) |
| Mar 2016 | $5.42B(-2.8%) | $1.52B(+14.0%) | $5.43B(+1.1%) |
| Dec 2015 | - | $1.33B(+7.4%) | $5.37B(-0.4%) |
| Sep 2015 | - | $1.24B(-6.7%) | $5.39B(-3.0%) |
| Jun 2015 | - | $1.33B(-9.1%) | $5.56B(-0.1%) |
| Mar 2015 | $5.58B(+0.4%) | $1.46B(+8.2%) | $5.57B(-19.5%) |
| Dec 2014 | - | $1.35B(-4.0%) | $6.91B(-15.3%) |
| Sep 2014 | - | $1.41B(+5.4%) | $8.16B(-12.0%) |
| Jun 2014 | - | $1.34B(-52.4%) | $9.27B(-11.2%) |
| Mar 2014 | $5.55B(+32.0%) | $2.81B(+8.1%) | $10.44B(-2.6%) |
| Dec 2013 | - | $2.60B(+3.1%) | $10.73B(-3.2%) |
| Sep 2013 | - | $2.52B(+0.7%) | $11.08B(-3.5%) |
| Jun 2013 | - | $2.51B(-19.0%) | $11.48B(-3.3%) |
| Mar 2013 | $4.21B | $3.09B(+4.8%) | $11.87B(-0.8%) |
| Dec 2012 | - | $2.95B(+1.0%) | $11.97B(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $2.92B(+0.7%) | $11.94B(+6.6%) |
| Jun 2012 | - | $2.90B(-9.0%) | $11.20B(+8.9%) |
| Mar 2012 | $8.51B(+20.3%) | $3.19B(+9.3%) | $10.28B(+9.4%) |
| Dec 2011 | - | $2.92B(+33.5%) | $9.40B(+15.0%) |
| Sep 2011 | - | $2.19B(+10.0%) | $8.17B(+7.8%) |
| Jun 2011 | - | $1.99B(-13.9%) | $7.59B(+1.0%) |
| Mar 2011 | $7.07B(-6.1%) | $2.31B(+36.5%) | $7.51B(+44.4%) |
| Dec 2010 | - | $1.69B(+5.9%) | $5.20B(+9.6%) |
| Sep 2010 | - | $1.60B(-16.5%) | $4.74B(-8.5%) |
| Jun 2010 | - | $1.91B(>+9900.0%) | $5.18B(+0.8%) |
| Mar 2010 | $7.53B(-13.5%) | $0.00(-100.0%) | $5.14B(0.0%) |
| Dec 2009 | - | $1.23B(-39.4%) | $5.14B(+31.6%) |
| Sep 2009 | - | $2.04B(+8.9%) | $3.91B(+108.9%) |
| Jun 2009 | - | $1.87B(>+9900.0%) | $1.87B(>+9900.0%) |
| Mar 2009 | $8.71B(+69.5%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2008 | $5.14B(+23.5%) | - | - |
| Mar 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2007 | $4.16B(+1.5%) | - | - |
| Mar 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2006 | $4.10B(+97.7%) | - | - |
| Mar 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2005 | $2.07B(+7.6%) | - | - |
| Mar 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00 | $0.00 |
| Mar 2004 | $1.93B(-31.0%) | - | - |
| Mar 2003 | $2.79B(+16.1%) | - | - |
| Mar 2002 | $2.41B(-12.5%) | - | - |
| Mar 2001 | $2.75B(+87.8%) | - | - |
| Mar 2000 | $1.46B(+54.1%) | - | - |
| Mar 1999 | $949.92M(-59.1%) | - | - |
| Mar 1998 | $2.32B(-0.1%) | - | - |
| Mar 1997 | $2.32B(-12.2%) | - | - |
| Mar 1996 | $2.65B(+4.9%) | - | - |
| Mar 1995 | $2.52B(+20.4%) | - | - |
| Mar 1994 | $2.10B(+18.0%) | - | - |
| Mar 1993 | $1.78B(+0.4%) | - | - |
| Mar 1992 | $1.77B(+12.7%) | - | - |
| Mar 1991 | $1.57B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual SG&A?
- What is the all-time high annual SG&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual SG&A year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly SG&A?
- What is the all-time high quarterly SG&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly SG&A year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM SG&A?
- What is the all-time high TTM SG&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM SG&A year-on-year change?
What is Takeda Pharmaceutical Company Limited annual SG&A?
The current annual SG&A of TAK is $7.25B
What is the all-time high annual SG&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual SG&A is $8.87B
What is Takeda Pharmaceutical Company Limited annual SG&A year-on-year change?
Over the past year, TAK annual SG&A has changed by -$40.98M (-0.56%)
What is Takeda Pharmaceutical Company Limited quarterly SG&A?
The current quarterly SG&A of TAK is $1.72B
What is the all-time high quarterly SG&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly SG&A is $3.19B
What is Takeda Pharmaceutical Company Limited quarterly SG&A year-on-year change?
Over the past year, TAK quarterly SG&A has changed by -$78.40M (-4.36%)
What is Takeda Pharmaceutical Company Limited TTM SG&A?
The current TTM SG&A of TAK is $31.94B
What is the all-time high TTM SG&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM SG&A is $115.93B
What is Takeda Pharmaceutical Company Limited TTM SG&A year-on-year change?
Over the past year, TAK TTM SG&A has changed by +$24.68B (+339.94%)